© 1996 American Heart Association, Inc.
Articles |
Myocyte Enhancer Binding Factor-2 Expression and Activity in Vascular Smooth Muscle Cells
Association With the Activated Phenotype
From the Department of Biochemistry and Molecular Biology (A.B.F., J.M.M., E.N.O.), University of Texas M.D. Anderson Cancer Center, Houston; the Division of Cardiology (W.B., W.C, J.J.S.), Department of Internal Medicine, University of Texas Medical School, Houston; and the Texas Heart Institute (A.D.J., W.C.), Houston.
Correspondence to Dr John J. Schwarz, Division of Cardiology, Department of Internal Medicine, University of Texas Medical School, Houston, TX 77030.
Abstract Proliferation and phenotypic modulation of smooth muscle cells (SMCs) are major components of the vessel's response to injury in experimental models of restenosis. Some of the growth factors involved in restenosis have been identified, but to date little is known about the transcription factors that ultimately regulate this process. We examined the expression of the four members of the myocyte enhancer binding factor-2 (MEF2) family of transcription factors in cultured rat aortic SMCs (RASMCs) and a rat model of restenosis because of their known importance in regulating the differentiated phenotype of skeletal and cardiac muscle. In skeletal and cardiac muscle, the MEF2s are believed to be important for activating the expression of contractile protein and other muscle-specific genes. Therefore, we anticipated that the MEF2s would be expressed at high levels in medial SMCs that are producing contractile proteins and that they would be downregulated along with the contractile protein genes in neointimal SMCs. On the contrary, we observe that MEF2A, MEF2B, and MEF2D mRNAs are upregulated in the neointima, with the highest levels in the layer of cells nearest to the lumen, whereas MEF2C mRNA levels do not appreciably increase. Moreover, few cells in the media are making MEF2 proteins detectable by immunohistochemistry, whereas large numbers of neointimal cells are positive for all four MEF2s. These data suggest that the MEF2s are involved in the activated smooth muscle phenotype and not in the maintenance of contractile protein gene expression.
Key Words: MEF2 • smooth muscle • transcription factor • balloon injury • mRNA
This article has been cited by other articles:
 |
|
 |
|
  J. W. Gordon, C. Pagiatakis, J. Salma, M. Du, J. J. Andreucci, J. Zhao, G. Hou, R. L. Perry, Q. Dan, D. Courtman, et al. Protein Kinase A-regulated Assembly of a MEF2{middle dot}HDAC4 Repressor Complex Controls c-Jun Expression in Vascular Smooth Muscle Cells J. Biol. Chem., July 10, 2009; 284(28): 19027 - 19042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gulec, A. Ruchan Akar, and N. Akar MEF2A Sequence Variants in Turkish Population Clinical and Applied Thrombosis/Hemostasis, October 1, 2008; 14(4): 465 - 467. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. Potthoff and E. N. Olson MEF2: a central regulator of diverse developmental programs Development, December 1, 2007; 134(23): 4131 - 4140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Gonzalez, M Garcia-Castro, J R Reguero, A Batalla, A G Ordonez, R L Palop, I Lozano, M Montes, V Alvarez, and E Coto The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction J. Med. Genet., February 1, 2006; 43(2): 167 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Goffin, D. Demonte, C. Vanhulle, S. de Walque, Y. de Launoit, A. Burny, Y. Collette, and C. Van Lint Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity Nucleic Acids Res., August 1, 2005; 33(13): 4285 - 4310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Suzuki, H. Satonaka, H. Nishimatsu, S. Oba, R. Takeda, M. Omata, T. Fujita, R. Nagai, and Y. Hirata Myocyte Enhancer Factor 2 Mediates Vascular Inflammation via the p38-Dependent Pathway Circ. Res., July 9, 2004; 95(1): 42 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Anderson, E. Dodou, A. B. Heidt, S. J. De Val, E. J. Jaehnig, S. B. Greene, E. N. Olson, and B. L. Black HRC Is a Direct Transcriptional Target of MEF2 during Cardiac, Skeletal, and Arterial Smooth Muscle Development In Vivo Mol. Cell. Biol., May 1, 2004; 24(9): 3757 - 3768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Olson Coronary Artery Disease and the MEF2A Transcription Factor Sci. Aging Knowl. Environ., December 3, 2003; 2003(48): pe33 - 33. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Wang, C. Fan, S. E. Topol, E. J. Topol, and Q. Wang Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease Science, November 28, 2003; 302(5650): 1578 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Linseman, C. M. Bartley, S. S. Le, T. A. Laessig, R. J. Bouchard, M. K. Meintzer, M. Li, and K. A. Heidenreich Inactivation of the Myocyte Enhancer Factor-2 Repressor Histone Deacetylase-5 by Endogenous Ca2//Calmodulin-dependent Kinase II Promotes Depolarization-mediated Cerebellar Granule Neuron Survival J. Biol. Chem., October 17, 2003; 278(42): 41472 - 41481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshida, S. Sinha, F. Dandre, B. R. Wamhoff, M. H. Hoofnagle, B. E. Kremer, D.-Z. Wang, E. N. Olson, and G. K. Owens Myocardin Is a Key Regulator of CArG-Dependent Transcription of Multiple Smooth Muscle Marker Genes Circ. Res., May 2, 2003; 92(8): 856 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Zingg, R. Ricciarelli, E. Andorno, and A. Azzi Novel 5' Exon of Scavenger Receptor CD36 Is Expressed in Cultured Human Vascular Smooth Muscle Cells and Atherosclerotic Plaques Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 412 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Li, D. A. Linseman, M. P. Allen, M. K. Meintzer, X. Wang, T. Laessig, M. E. Wierman, and K. A. Heidenreich Myocyte Enhancer Factor 2A and 2D Undergo Phosphorylation and Caspase-Mediated Degradation during Apoptosis of Rat Cerebellar Granule Neurons J. Neurosci., September 1, 2001; 21(17): 6544 - 6552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Halayko and J. Solway Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Molecular mechanisms of phenotypic plasticity in smooth muscle cells J Appl Physiol, January 1, 2001; 90(1): 358 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kawai-Kowase, M. Kurabayashi, Y. Hoshino, Y. Ohyama, and R. Nagai Transcriptional Activation of the Zinc Finger Transcription Factor BTEB2 Gene by Egr-1 Through Mitogen-Activated Protein Kinase Pathways in Vascular Smooth Muscle Cells Circ. Res., October 29, 1999; 85(9): 787 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Watanabe, M. Kurabayashi, Y. Shimomura, K. Kawai-Kowase, Y.-i. Hoshino, I. Manabe, M. Watanabe, M. Aikawa, M. Kuro-o, T. Suzuki, et al. BTEB2, a Kruppel-Like Transcription Factor, Regulates Expression of the SMemb/Nonmuscle Myosin Heavy Chain B (SMemb/NMHC-B) Gene Circ. Res., July 23, 1999; 85(2): 182 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mikami, T. Kusakabe, and N. Suzuki Tandem Organization of Medaka Fish Soluble Guanylyl Cyclase alpha 1 and beta 1 Subunit Genes. IMPLICATIONS FOR COORDINATED TRANSCRIPTION OF TWO SUBUNIT GENES J. Biol. Chem., June 25, 1999; 274(26): 18567 - 18573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kasahara, S. Bartunkova, M. Schinke, M. Tanaka, and S. Izumo Cardiac and Extracardiac Expression of Csx/Nkx2.5 Homeodomain Protein Circ. Res., May 19, 1998; 82(9): 936 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zilberman, V. Dave, J. Miano, E. N. Olson, and M. Periasamy Evolutionarily Conserved Promoter Region Containing CArG*-Like Elements Is Crucial for Smooth Muscle Myosin Heavy Chain Gene Expression Circ. Res., March 23, 1998; 82(5): 566 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Shanahan and P. L. Weissberg Smooth Muscle Cell Heterogeneity : Patterns of Gene Expression in Vascular Smooth Muscle Cells In Vitro and In Vivo Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 333 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Katoh, J. D. Molkentin, V. Dave, E. N. Olson, and M. Periasamy MEF2B Is a Component of a Smooth Muscle-specific Complex That Binds an A/T-rich Element Important for Smooth Muscle Myosin Heavy Chain Gene Expression J. Biol. Chem., January 16, 1998; 273(3): 1511 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q Lin, J Lu, H Yanagisawa, R Webb, G. Lyons, J. Richardson, and E. Olson Requirement of the MADS-box transcription factor MEF2C for vascular development Development, January 11, 1998; 125(22): 4565 - 4574. [Abstract] [PDF]
|
|
|
|
|
|
C. S. Madsen, C. P. Regan, and G. K. Owens Interaction of CArG Elements and a GC-rich Repressor Element in Transcriptional Regulation of the Smooth Muscle Myosin Heavy Chain Gene in Vascular Smooth Muscle Cells J. Biol. Chem., November 21, 1997; 272(47): 29842 - 29851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Lin, J. Schwarz, C. Bucana, and E. N. Olson Control of Mouse Cardiac Morphogenesis and Myogenesis by Transcription Factor MEF2C Science, May 30, 1997; 276(5317): 1404 - 1407. [Abstract] [Full Text]
|
|
|
|
|
|
L. Li, J. M. Miano, P. Cserjesi, and E. N. Olson SM22{alpha}, a Marker of Adult Smooth Muscle, Is Expressed in Multiple Myogenic Lineages During Embryogenesis Circ. Res., February 1, 1996; 78(2): 188 - 195. [Abstract] [Full Text]
|
|
|
|
|
|
M. P. Allen, M. Xu, C. Zeng, S. A. Tobet, and M. E. Wierman Myocyte Enhancer Factors-2B and -2C Are Required for Adhesion Related Kinase Repression of Neuronal Gonadotropin Releasing Hormone Gene Expression J. Biol. Chem., December 8, 2000; 275(50): 39662 - 39670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Phiel, V. Gabbeta, L. M. Parsons, D. Rothblat, R. P. Harvey, and K. M. McHugh Differential Binding of an SRF/NK-2/MEF2 Transcription Factor Complex in Normal Versus Neoplastic Smooth Muscle Tissues J. Biol. Chem., September 7, 2001; 276(37): 34637 - 34650. [Abstract] [Full Text] [PDF]
|
|